← Leaderboards
Sebastian Polak
Certara Uk Limited
$1,573,193
Attributed
$1,939,199
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $299.4K · FY2014–25$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
FDA$1,939,199 · 4
By mechanism
U01$1,939,199 · 4
Top collaborators
- Ming Hu2 shared
- Feng Zhang2 shared
Grant awards (9)
Developing PBPK-model based mechanistic IVIVC for PLGA implants$249,645
U01 · FY2025 · FD
Developing PBPK-model based mechanistic IVIVC for PLGA implants$299,364
U01 · FY2024 · FD
Progressing integration of in vitro topical formulation characterisation, release and permeation data to the next level - PBPK based extrapolation to bioequivalence assessment in virtual populations$249,941
U01 · FY2022 · FD · contact PI
Progressing integration of in vitro topical formulation characterisation, release and permeation data to the next level - PBPK based extrapolation to bioequivalence assessment in virtual populations$249,891
U01 · FY2021 · FD · contact PI
Characterization of key system parameters of mechanistic dermal PBPK models in various skin diseases and performance verification of the model using observed local and systemic concentrations$249,406
U01 · FY2019 · FD · contact PI
Characterization of key system parameters of mechanistic dermal PBPK models in various skin diseases and performance verification of the model using observed local and systemic concentrations$249,443
U01 · FY2018 · FD · contact PI
Development and validation of dermal PBPK modelling platform towards virtual bioequivalence assessment considering population variability$134,950
U01 · FY2016 · FD · contact PI
Development and validation of dermal PBPK modelling platform towards virtual bioequivalence assessment considering population variability$130,445
U01 · FY2015 · FD · contact PI
Development and validation of dermal PBPK modelling platform towards virtual bioequivalence assessment considering population variability$126,114
U01 · FY2014 · FD · contact PI